Click here to get full coverage on Trusting Instinct: When NSCLC Decisions Can’t Wait for NGS - Medscape

Trusting Instinct: When NSCLC Decisions Can’t Wait for NGS  Medscape

Trusting Instinct: When NSCLC Decisions Can’t Wait for NGS - Medscape

Click here to get full coverage on Cryptic AML Gene Fusions Identified Through Enhanced NGS Panel - Inside Precision Medicine

Cryptic AML Gene Fusions Identified Through Enhanced NGS Panel  Inside Precision Medicine

Cryptic AML Gene Fusions Identified Through Enhanced NGS Panel - Inside Precision Medicine

Click here to get full coverage on Challenges to NGS Testing for Follicular Lymphoma in the Community Setting - The American Journal of Managed Care® (AJMC®)

Challenges to NGS Testing for Follicular Lymphoma in the Community Setting  The American Journal of Managed Care® (AJMC®)

Challenges to NGS Testing for Follicular Lymphoma in the Community Setting - The American Journal of Managed Care® (AJMC®)

Click here to get full coverage on NGS Streamlines Clonal Detection in Plasma Cells - Conexiant

NGS Streamlines Clonal Detection in Plasma Cells  Conexiant

NGS Streamlines Clonal Detection in Plasma Cells - Conexiant

Click here to get full coverage on Bringing accessible NGS-based proteomics to even more labs - News-Medical

Bringing accessible NGS-based proteomics to even more labs  News-Medical

Bringing accessible NGS-based proteomics to even more labs - News-Medical

Click here to get full coverage on Implementing liquid biopsy NGS in stage III/IV NSCLC: clinical utility assessment from a real-world Chinese cohort - BMC Cancer

Implementing liquid biopsy NGS in stage III/IV NSCLC: clinical utility assessment from a real-world Chinese cohort  BMC Cancer

Implementing liquid biopsy NGS in stage III/IV NSCLC: clinical utility assessment from a real-world Chinese cohort - BMC Cancer

Click here to get full coverage on OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel - the-scientist.com

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel  the-scientist.com

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel - the-scientist.com

Click here to get full coverage on Are Oils-Energy Stocks Lagging Natural Gas Services Group (NGS) This Year? - Yahoo Finance

Are Oils-Energy Stocks Lagging Natural Gas Services Group (NGS) This Year?  Yahoo Finance

Are Oils-Energy Stocks Lagging Natural Gas Services Group (NGS) This Year? - Yahoo Finance

Click here to get full coverage on Clear Labs Showcases Oncology NGS Automation Initiatives and Announces Collaboration with Labcorp - PRWeb

Clear Labs Showcases Oncology NGS Automation Initiatives and Announces Collaboration with Labcorp  PRWeb

Clear Labs Showcases Oncology NGS Automation Initiatives and Announces Collaboration with Labcorp - PRWeb

Click here to get full coverage on Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc. - PR Newswire

Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc.  PR Newswire

Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc. - PR Newswire

Click here to get full coverage on NGS Streamlines Biomarker Testing in Solid Tumors - Oncology Nursing News

NGS Streamlines Biomarker Testing in Solid Tumors  Oncology Nursing News

NGS Streamlines Biomarker Testing in Solid Tumors - Oncology Nursing News

Click here to get full coverage on OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel - Drug Discovery News

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel  Drug Discovery News

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel - Drug Discovery News

Click here to get full coverage on $NGS stock is down 9% today. Here's what we see in our data. - Quiver Quantitative

$NGS stock is down 9% today. Here's what we see in our data.  Quiver Quantitative

$NGS stock is down 9% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Twist Bioscience Corp SEC 10-K Report - TradingView

Twist Bioscience Corp SEC 10-K Report  TradingView

Twist Bioscience Corp SEC 10-K Report - TradingView

Click here to get full coverage on Now that NGS is more affordable, how can we make it easier? - Illumina

Now that NGS is more affordable, how can we make it easier?  Illumina

Now that NGS is more affordable, how can we make it easier? - Illumina

Click here to get full coverage on NGS Reports Record-Breaking Earnings and Growth Outlook - TipRanks

NGS Reports Record-Breaking Earnings and Growth Outlook  TipRanks

NGS Reports Record-Breaking Earnings and Growth Outlook - TipRanks

Click here to get full coverage on Consensus Guidelines for NGS in Sarcoma Diagnosis, Treatment - Managed Healthcare Executive

Consensus Guidelines for NGS in Sarcoma Diagnosis, Treatment  Managed Healthcare Executive

Consensus Guidelines for NGS in Sarcoma Diagnosis, Treatment - Managed Healthcare Executive

Click here to get full coverage on Long-Term Data Reveal NGS Adoption Trend in LDTs - Conexiant

Long-Term Data Reveal NGS Adoption Trend in LDTs  Conexiant

Long-Term Data Reveal NGS Adoption Trend in LDTs - Conexiant

Click here to get full coverage on Here's Why Momentum in Natural Gas Services (NGS) Should Keep going - Yahoo Finance

Here's Why Momentum in Natural Gas Services (NGS) Should Keep going  Yahoo Finance

Here's Why Momentum in Natural Gas Services (NGS) Should Keep going - Yahoo Finance

Click here to get full coverage on Volta Labs and New England Biolabs Partner to Expand Automated NGS Library Preparation on the Callisto Platform - Yahoo Finance

Volta Labs and New England Biolabs Partner to Expand Automated NGS Library Preparation on the Callisto Platform  Yahoo Finance

Volta Labs and New England Biolabs Partner to Expand Automated NGS Library Preparation on the Callisto Platform - Yahoo Finance

Click here to get full coverage on Natural Gas Services (NGS) Beats Q3 Earnings and Revenue Estimates - Yahoo Finance

Natural Gas Services (NGS) Beats Q3 Earnings and Revenue Estimates  Yahoo Finance

Natural Gas Services (NGS) Beats Q3 Earnings and Revenue Estimates - Yahoo Finance

Click here to get full coverage on Integrated DNA Technologies and Beckman Coulter Life Sciences Partner to Advance Cancer Research Through Automated NGS Workflows - Business Wire

Integrated DNA Technologies and Beckman Coulter Life Sciences Partner to Advance Cancer Research Through Automated NGS Workflows  Business Wire

Integrated DNA Technologies and Beckman Coulter Life Sciences Partner to Advance Cancer Research Through Automated NGS Workflows - Business Wire

Click here to get full coverage on Next-generation sequencing (NGS) - Roche

Next-generation sequencing (NGS)  Roche

Next-generation sequencing (NGS) - Roche

Click here to get full coverage on Pillar Biosciences Announce Automated NGS Library Preparation Method on Hamilton Microlab STAR to Accelerate Myeloproliferative Neoplasm Research - PR Newswire

Pillar Biosciences Announce Automated NGS Library Preparation Method on Hamilton Microlab STAR to Accelerate Myeloproliferative Neoplasm Research  PR Newswire

Pillar Biosciences Announce Automated NGS Library Preparation Method on Hamilton Microlab STAR to Accelerate Myeloproliferative Neoplasm Research - PR Newswire

Click here to get full coverage on The Power Behind a 19.3% CAGR in NGS-Based RNA Sequencing Market - industrytoday.co.uk

The Power Behind a 19.3% CAGR in NGS-Based RNA Sequencing Market  industrytoday.co.uk

The Power Behind a 19.3% CAGR in NGS-Based RNA Sequencing Market - industrytoday.co.uk

Click here to get full coverage on Earnings To Watch: Natural Gas Services Group Inc (NGS) Reports Q3 2025 Result - Yahoo Finance

Earnings To Watch: Natural Gas Services Group Inc (NGS) Reports Q3 2025 Result  Yahoo Finance

Earnings To Watch: Natural Gas Services Group Inc (NGS) Reports Q3 2025 Result - Yahoo Finance

Click here to get full coverage on Pillar Biosciences to Showcase NGS Research Insights at 2025 AMP Meeting - PR Newswire

Pillar Biosciences to Showcase NGS Research Insights at 2025 AMP Meeting  PR Newswire

Pillar Biosciences to Showcase NGS Research Insights at 2025 AMP Meeting - PR Newswire

Click here to get full coverage on Prognostic impact of early NGS MRD dynamics and cytomolecular risk in newly diagnosed B-cell ALL - Nature

Prognostic impact of early NGS MRD dynamics and cytomolecular risk in newly diagnosed B-cell ALL  Nature

Prognostic impact of early NGS MRD dynamics and cytomolecular risk in newly diagnosed B-cell ALL - Nature

Click here to get full coverage on NGS and IHC in Sarcoma at CUHK Sarcoma Masterclass - Oncodaily

NGS and IHC in Sarcoma at CUHK Sarcoma Masterclass  Oncodaily

NGS and IHC in Sarcoma at CUHK Sarcoma Masterclass - Oncodaily

Click here to get full coverage on Natural Gas Services Group, Inc. (NYSE:NGS) Q3 2025 Earnings Call Transcript - Insider Monkey

Natural Gas Services Group, Inc. (NYSE:NGS) Q3 2025 Earnings Call Transcript  Insider Monkey

Natural Gas Services Group, Inc. (NYSE:NGS) Q3 2025 Earnings Call Transcript - Insider Monkey

Click here to get full coverage on Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks - Yahoo Finance

Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks  Yahoo Finance

Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks - Yahoo Finance

Click here to get full coverage on Critical interventions: The growing use of NGS for patients with infections - Illumina

Critical interventions: The growing use of NGS for patients with infections  Illumina

Critical interventions: The growing use of NGS for patients with infections - Illumina

Click here to get full coverage on A targeted next-generation sequencing panel for identification of clinically relevant mutation profiles in solid tumours - Nature

A targeted next-generation sequencing panel for identification of clinically relevant mutation profiles in solid tumours  Nature

A targeted next-generation sequencing panel for identification of clinically relevant mutation profiles in solid tumours - Nature

Click here to get full coverage on Chris Eubank admitted that one error cost Nigel Benn his revenge in their iconic rematch - Bloody Elbow

Chris Eubank admitted that one error cost Nigel Benn his revenge in their iconic rematch  Bloody Elbow

Chris Eubank admitted that one error cost Nigel Benn his revenge in their iconic rematch - Bloody Elbow

Click here to get full coverage on Paragon Genomics Introduces New CleanPlex® NGS Panel for Pharmacogenomics Profiling at AMP 2025 - The Manila Times

Paragon Genomics Introduces New CleanPlex® NGS Panel for Pharmacogenomics Profiling at AMP 2025  The Manila Times

Paragon Genomics Introduces New CleanPlex® NGS Panel for Pharmacogenomics Profiling at AMP 2025 - The Manila Times

Click here to get full coverage on Next-generation sequencing & SBX: 5 exciting things to know - Roche

Next-generation sequencing & SBX: 5 exciting things to know  Roche

Next-generation sequencing & SBX: 5 exciting things to know - Roche

Click here to get full coverage on The State of Multiomics & NGS - Genetic Engineering and Biotechnology News

The State of Multiomics & NGS  Genetic Engineering and Biotechnology News

The State of Multiomics & NGS - Genetic Engineering and Biotechnology News

Click here to get full coverage on AMP 2025: DNAe to unveil latest data from world's first NGS-based, fully automated sample-to-result diagnostic platform - Yahoo Finance

AMP 2025: DNAe to unveil latest data from world's first NGS-based, fully automated sample-to-result diagnostic platform  Yahoo Finance

AMP 2025: DNAe to unveil latest data from world's first NGS-based, fully automated sample-to-result diagnostic platform - Yahoo Finance

Click here to get full coverage on Prepare your data for the National Spatial Reference System modernization of 2022 in the U.S. (ArcGIS Blog) - Esri

Prepare your data for the National Spatial Reference System modernization of 2022 in the U.S. (ArcGIS Blog)  Esri

Prepare your data for the National Spatial Reference System modernization of 2022 in the U.S. (ArcGIS Blog) - Esri

Click here to get full coverage on Restoring Nature with NGS: The Role of Automation in Conservation Science - the-scientist.com

Restoring Nature with NGS: The Role of Automation in Conservation Science  the-scientist.com

Restoring Nature with NGS: The Role of Automation in Conservation Science - the-scientist.com

Click here to get full coverage on Press Release Service: United States Next Generation Sequencing (NGS) Market Research 2025-2033: Personalized Medicine, Research Applications, and Advances in Automation Propel Growth - ResearchAndMarkets.com - CRISPR Medicine News

Press Release Service: United States Next Generation Sequencing (NGS) Market Research 2025-2033: Personalized Medicine, Research Applications, and Advances in Automation Propel Growth - ResearchAndMarkets.com  CRISPR Medicine News

Press Release Service: United States Next Generation Sequencing (NGS) Market Research 2025-2033: Personalized Medicine, Research Applications, and Advances in Automation Propel Growth - ResearchAndMarkets.com - CRISPR Medicine News

Click here to get full coverage on Dr Mulherin on Using AI to Address NGS Testing Barriers in Oncology Practice - OncLive

Dr Mulherin on Using AI to Address NGS Testing Barriers in Oncology Practice  OncLive

Dr Mulherin on Using AI to Address NGS Testing Barriers in Oncology Practice - OncLive

Click here to get full coverage on NGS-based RNA-sequencing Market | Industry Report, 2030 - Grand View Research

NGS-based RNA-sequencing Market | Industry Report, 2030  Grand View Research

NGS-based RNA-sequencing Market | Industry Report, 2030 - Grand View Research

Click here to get full coverage on NGS is evolving: collaboration and tech lead the way - Drug Target Review

NGS is evolving: collaboration and tech lead the way  Drug Target Review

NGS is evolving: collaboration and tech lead the way - Drug Target Review

Click here to get full coverage on The Best of NGS: Instrument Companies to Watch in 2025 - Genetic Engineering and Biotechnology News

The Best of NGS: Instrument Companies to Watch in 2025  Genetic Engineering and Biotechnology News

The Best of NGS: Instrument Companies to Watch in 2025 - Genetic Engineering and Biotechnology News

Click here to get full coverage on Natural Gas Services Group (NYSE:NGS) Issues Earnings Results - MarketBeat

Natural Gas Services Group (NYSE:NGS) Issues Earnings Results  MarketBeat

Natural Gas Services Group (NYSE:NGS) Issues Earnings Results - MarketBeat

Click here to get full coverage on University Leading Effort to Bring NGS to NY State Courts - Forensic Mag

University Leading Effort to Bring NGS to NY State Courts  Forensic Mag

University Leading Effort to Bring NGS to NY State Courts - Forensic Mag

Click here to get full coverage on GENE SOLUTIONS AND ELEMENT BIOSCIENCES ENTER STRATEGIC COLLABORATION TO ADVANCE NEXT-GENERATION SEQUENCING (NGS) TECHNOLOGY GLOBALLY - PR Newswire

GENE SOLUTIONS AND ELEMENT BIOSCIENCES ENTER STRATEGIC COLLABORATION TO ADVANCE NEXT-GENERATION SEQUENCING (NGS) TECHNOLOGY GLOBALLY  PR Newswire

GENE SOLUTIONS AND ELEMENT BIOSCIENCES ENTER STRATEGIC COLLABORATION TO ADVANCE NEXT-GENERATION SEQUENCING (NGS) TECHNOLOGY GLOBALLY - PR Newswire

Click here to get full coverage on FDA Approves NGS-Based Companion Diagnostic for Zongertinib in NSCLC - CancerNetwork

FDA Approves NGS-Based Companion Diagnostic for Zongertinib in NSCLC  CancerNetwork

FDA Approves NGS-Based Companion Diagnostic for Zongertinib in NSCLC - CancerNetwork

Click here to get full coverage on NGS-Based RNA-Sequencing Market Latest Report 2025 - InsightAce Analytic

NGS-Based RNA-Sequencing Market Latest Report 2025  InsightAce Analytic

NGS-Based RNA-Sequencing Market Latest Report 2025 - InsightAce Analytic

Click here to get full coverage on Rare Disease Research Gets a Boost from Automated NGS Solutions - the-scientist.com

Rare Disease Research Gets a Boost from Automated NGS Solutions  the-scientist.com

Rare Disease Research Gets a Boost from Automated NGS Solutions - the-scientist.com

Click here to get full coverage on Genomics, in a flash: A DNA sequencing world record - Roche

Genomics, in a flash: A DNA sequencing world record  Roche

Genomics, in a flash: A DNA sequencing world record - Roche

Click here to get full coverage on Integrated DNA Technologies and Hamilton Partner to Automate Customizable NGS Workflows and Accelerate Biomarker Discovery - Business Wire

Integrated DNA Technologies and Hamilton Partner to Automate Customizable NGS Workflows and Accelerate Biomarker Discovery  Business Wire

Integrated DNA Technologies and Hamilton Partner to Automate Customizable NGS Workflows and Accelerate Biomarker Discovery - Business Wire

Click here to get full coverage on Avance Biosciences Launches NGS Center of Excellence in Houston - PR Newswire

Avance Biosciences Launches NGS Center of Excellence in Houston  PR Newswire

Avance Biosciences Launches NGS Center of Excellence in Houston - PR Newswire

Click here to get full coverage on Paragon Genomics Introduces New CleanPlex® NGS Panel for Pharmacogenomics Profiling at AMP 2025 - Bluefield Daily Telegraph

Paragon Genomics Introduces New CleanPlex® NGS Panel for Pharmacogenomics Profiling at AMP 2025  Bluefield Daily Telegraph

Paragon Genomics Introduces New CleanPlex® NGS Panel for Pharmacogenomics Profiling at AMP 2025 - Bluefield Daily Telegraph

Click here to get full coverage on Thermo Fisher’s NGS Assay Receives FDA Approval as a Companion Diagnostic for ZEGFROVY and for Tumor Profiling - Business Wire

Thermo Fisher’s NGS Assay Receives FDA Approval as a Companion Diagnostic for ZEGFROVY and for Tumor Profiling  Business Wire

Thermo Fisher’s NGS Assay Receives FDA Approval as a Companion Diagnostic for ZEGFROVY and for Tumor Profiling - Business Wire

Click here to get full coverage on FDA OKs NGS Test for Tumor Profiling and as CDx for Sunvozertinib in NSCLC - CancerNetwork

FDA OKs NGS Test for Tumor Profiling and as CDx for Sunvozertinib in NSCLC  CancerNetwork

FDA OKs NGS Test for Tumor Profiling and as CDx for Sunvozertinib in NSCLC - CancerNetwork

Click here to get full coverage on LAURA Study: NGS Testing in Diagnosis of NSCLC - Targeted Oncology

LAURA Study: NGS Testing in Diagnosis of NSCLC  Targeted Oncology

LAURA Study: NGS Testing in Diagnosis of NSCLC - Targeted Oncology

Click here to get full coverage on Pillar Biosciences and Hamilton Company Announce NGS Application Development and Co-Marketing Agreement - PR Newswire

Pillar Biosciences and Hamilton Company Announce NGS Application Development and Co-Marketing Agreement  PR Newswire

Pillar Biosciences and Hamilton Company Announce NGS Application Development and Co-Marketing Agreement - PR Newswire

Click here to get full coverage on US NGS Market Forecast and Company Analysis Report 2025-2033: Illumina, Thermo Fisher Scientific, Pacific Biosciences, QIAGEN, Roche, Bio-Rad Laboratories, Takara Bio, Hamilton, Geneious, BioMerieux - Yahoo Finance

US NGS Market Forecast and Company Analysis Report 2025-2033: Illumina, Thermo Fisher Scientific, Pacific Biosciences, QIAGEN, Roche, Bio-Rad Laboratories, Takara Bio, Hamilton, Geneious, BioMerieux  Yahoo Finance

US NGS Market Forecast and Company Analysis Report 2025-2033: Illumina, Thermo Fisher Scientific, Pacific Biosciences, QIAGEN, Roche, Bio-Rad Laboratories, Takara Bio, Hamilton, Geneious, BioMerieux - Yahoo Finance

Click here to get full coverage on IHC Testing Could Serve as Surrogate to NGS for Early Detection of TP53-Mutant MDS/AML - OncLive

IHC Testing Could Serve as Surrogate to NGS for Early Detection of TP53-Mutant MDS/AML  OncLive

IHC Testing Could Serve as Surrogate to NGS for Early Detection of TP53-Mutant MDS/AML - OncLive

Click here to get full coverage on Wall Street Analysts Think Natural Gas Services (NGS) Could Surge 38.57%: Read This Before Placing a Bet - Yahoo Finance

Wall Street Analysts Think Natural Gas Services (NGS) Could Surge 38.57%: Read This Before Placing a Bet  Yahoo Finance

Wall Street Analysts Think Natural Gas Services (NGS) Could Surge 38.57%: Read This Before Placing a Bet - Yahoo Finance

Click here to get full coverage on Palo Alto Networks Hits $5B in NGS ARR: What's Fueling the Surge? - Yahoo Finance

Palo Alto Networks Hits $5B in NGS ARR: What's Fueling the Surge?  Yahoo Finance

Palo Alto Networks Hits $5B in NGS ARR: What's Fueling the Surge? - Yahoo Finance

Click here to get full coverage on Now on demand! OncomineWorld 2025: A virtual NGS education meeting - Labroots

Now on demand! OncomineWorld 2025: A virtual NGS education meeting  Labroots

Now on demand! OncomineWorld 2025: A virtual NGS education meeting - Labroots

Click here to get full coverage on The future of precision oncology: Scaling NGS with smarter variant interpretation - Illumina

The future of precision oncology: Scaling NGS with smarter variant interpretation  Illumina

The future of precision oncology: Scaling NGS with smarter variant interpretation - Illumina

Click here to get full coverage on Integrated DNA Technologies and Hamilton Partner to Automate Customizable NGS Workflows and Accelerate Biomarker Discovery - Yahoo Finance

Integrated DNA Technologies and Hamilton Partner to Automate Customizable NGS Workflows and Accelerate Biomarker Discovery  Yahoo Finance

Integrated DNA Technologies and Hamilton Partner to Automate Customizable NGS Workflows and Accelerate Biomarker Discovery - Yahoo Finance

Click here to get full coverage on Dr Vento on the Clinical Significance of Somatic NGS in Guiding Treatment Decisions for Non–Clear Cell RCC - OncLive

Dr Vento on the Clinical Significance of Somatic NGS in Guiding Treatment Decisions for Non–Clear Cell RCC  OncLive

NGS

Price Chart

Key Statistics

Technicals

About NGS

Latest News

Trusting Instinct: When NSCLC Decisions Can’t Wait for NGS - Medscape

Cryptic AML Gene Fusions Identified Through Enhanced NGS Panel - Inside Precision Medicine

Challenges to NGS Testing for Follicular Lymphoma in the Community Setting - The American Journal of Managed Care® (AJMC®)

Advanced Charts

Top Gainers

Top Losers